ISS Backs Cigna-Express Scripts Deal

Carl Icahn’s effort to find enough allies to block Cigna’s $54 billion proposed purchase of Express Scripts got a little harder Friday after proxy-advisory firm Institutional Shareholder Services recommended shareholders support the deal.
Source: Wall Street